SAB Biotherapeutics, Inc.
New Filing
CIK: 0001833214·Biotechnology·DELAWARE·Filed: Oct 16, 2023
Total Offering
$7,500,000
Amount Sold
$7,500,000
Investors
13
First Sale
Oct 2, 2023
Offering Details
- Type
- Equity, Option to Acquire
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2020
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Eddie J. Sullivan | Related Person |
| Russell Beyer | Related Person |
| Samuel J. Reich | Related Person |
| Christine Hamilton | Related Person |
| Scott Giberson | Related Person |
| David Charles Link | Related Person |
| Erick Lucera | Related Person |
| William Polvino | Related Person |
| Jeffrey G. Spragens | Related Person |
| Andrew Moin | Related Person |
Company
SEC Filing
0001209191-23-052843
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free